Veterinary Orthopedic Medicine Market Report 2026

Veterinary Orthopedic Medicine Market Overview

• Veterinary Orthopedic Medicine market size has reached to $4.03 billion in 2025 • Expected to grow to $5.99 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Rising Incidence Of Pet Orthopedic Diseases Fueling Market Expansion • Market Trend: Advancements in Veterinary Orthopedic Medicine: Major Companies Invest in 3D Printing, Regenerative Therapies, and Personalized Care • North America was the largest region in 2025.

What Is Covered Under Veterinary Orthopedic Medicine Market?

Veterinary orthopedic medicine is a specialized field within veterinary medicine focused on diagnosing, treating, and preventing disorders and injuries of the musculoskeletal system in animals. It encompasses a range of conditions such as fractures, arthritis, congenital deformities, and soft tissue injuries and involves various treatments, including surgical interventions, physical therapy, and rehabilitation to restore mobility and functionality in animals. The main products of veterinary orthopedic medicine are biologics, viscosupplements, and pharmaceuticals. Biologics are substances from living cells or organisms that treat diseases or injuries. The various animal types involved are canine, feline, equine, cattle, swine, and others. The multiple applications involved are osteoarthritis, degenerative joint disease, joint inflammation or pain, and others which is used by veterinary hospitals, veterinary clinics, other end users

What Is The Veterinary Orthopedic Medicine Market Growth Forecast?

The veterinary orthopedic medicine market size is expected to see strong growth in the next few years. It will grow to $5.99 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to advancements in prp and stem cell therapies, increasing use of viscosupplements and nsaids, adoption of advanced surgical techniques, growing investment in veterinary orthopedic research, rising awareness of animal mobility and quality of life. Major trends in the forecast period include rising prevalence of musculoskeletal disorders in animals, increasing adoption of minimally invasive orthopedic surgeries, growth in stem cell and biologics-based treatments, expansion of veterinary rehabilitation and physiotherapy services, emphasis on pain management and post-surgery recovery.

Global Veterinary Orthopedic Medicine Market Segmentation

1) By Product: Biologics, Viscosupplements, Pharmaceuticals 2) By Animal Type: Canine, Feline, Equine, Cattle, Swine, Other Animal Types 3) By Application: Osteoarthritis, Degenerative Joint Disease, Joint Inflammation Or Pain, Other Applications 4) By End-use: Veterinary Hospitals, Veterinary Clinics, Other End Users Subsegments: 1) By Biologics: Platelet-Rich Plasma (PRP), Stem Cell Therapy, Bone Marrow Aspirate Concentrate (BMAC), Viscosupplements 2) By Viscosupplements: Hyaluronic Acid, Corticosteroid Injections 3) By Pharmaceuticals: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Antibiotics

What Is The Driver Of The Veterinary Orthopedic Medicine Market?

The increasing incidence of pet orthopedic diseases is expected to propel the growth of the veterinary orthopedic medicine market going forward. Pet orthopedic diseases refer to conditions affecting the musculoskeletal system of companion animals, particularly dogs and cats. The increasing incidence of pet orthopedic diseases can be attributed to factors such as breed predispositions, rising rates of obesity, and environmental factors such as inadequate exercise and poor nutrition. Veterinary orthopedic medicine plays a crucial role in diagnosing, treating, and managing orthopedic diseases in pets, helping to alleviate pain, restore mobility, and improve the overall quality of life. For instance, in July 2024, according to a report by the Morris Animal Foundation, a US-based non-profit organization, over 14 million adult dogs in the United States were reported to suffer from osteoarthritis. Additionally, data indicates that around 90% of cats over the age of 12 exhibit radiographic signs of osteoarthritis, underscoring the high prevalence of this condition in aging pets and highlighting a growing need for awareness and advancement in treatment options. Therefore, the increasing incidence of pet orthopedic diseases is driving the growth of the veterinary orthopedic medicine industry.

Key Players In The Global Veterinary Orthopedic Medicine Market

Major companies operating in the veterinary orthopedic medicine market are Zoetis Inc., Elanco Animal Health, Merck Animal Health, Virbac SA, Ceva Santé Animale, Vetoquinol S.A., Bimeda U.S., American Regent, Hyalogic LLC, BioMedtrix LLC, IMEX Veterinary Inc., Orthomed (UK) Ltd, Veterinary Orthopedic Implants, Integra LifeSciences, Avante Animal Health, DePuy Synthes Vet, KYON AG, Securos Surgical, Arthrex Vet Systems, INNOPLANT Medizintechnik GmbH, VetWelding AG, Scil Animal Care, Intrauma S.p.A., Aysam Veterinary Orthopedics

Global Veterinary Orthopedic Medicine Market Trends and Insights

Major companies operating in veterinary orthopedic medicine are focused on investing in cutting-edge technologies, such as 3D printing lab for custom implants, regenerative medicine including stem cell and platelet-rich plasma (PRP) therapies, and advanced imaging techniques like MRI and CT scans tailored for animal patients. A 3D Printing Lab for Pet Orthopedic Surgeries is a specialized facility that utilizes 3D printing technology to create custom implants, prosthetics, and surgical tools specifically designed for veterinary orthopedic procedures. For instance, in October 2024, VCA Animal Hospitals, a U.S.-based company that offers high-quality veterinary care for pets launched the 3D printing lab at its VCA Northwest Veterinary Specialists facility in Clackamas, Oregon. This lab, which utilizes advanced 3D printing technology, aims to enhance orthopedic surgeries for pets by creating custom implants and surgical guides tailored to each pet's unique anatomy. Osteoarthritis, which affects 20% of dogs older than one year and 80% of those over eight, often necessitates surgical intervention. With this personalized approach, VCA seeks to promote faster recovery times and improved surgical outcomes, addressing complex orthopedic conditions more effectively than traditional methods.

What Are Latest Mergers And Acquisitions In The Veterinary Orthopedic Medicine Market?

In March 2025, Creative Science, a US-based veterinary medical technology company, acquired Infiniti Medical LLC and its subsidiary Orthomed UK Ltd for an undisclosed amount. With this acquisition, Creative Science aimed to expand its veterinary innovation portfolio by enhancing its product offerings and educational initiatives in interventional radiology, cardiology, soft tissue surgery, and orthopedic veterinary care. Infiniti Medical LLC is a US-based veterinary medical technology company that specializes in developing advanced veterinary technologies and devices.

Regional Outlook

North America was the largest region in the veterinary orthopedic medicine market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Orthopedic Medicine Market?

The veterinary orthopedic medicine market includes revenues earned by entities by providing services such as diagnosing, treating, and preventing musculoskeletal disorders and injuries in animals. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary orthopedic medicine market also includes sales of intramedullary devices, external fixation devices, and joint implants. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.